Cardiovascular news

New MIMS table summarises dosing of novel oral anticoagulants for stroke prevention

New MIMS table summarises dosing of novel oral anticoagulants for stroke prevention

GPs can now consult a handy MIMS table to help them...

GPs should no longer prescribe 18 'low value' treatments, NHS England rules

GPs should no longer prescribe 18 'low value' treatments, NHS England rules

NHS England believes cutting access to the treatments,...

Prescribe quinine with caution in patients at risk of QT prolongation, MHRA advises

Prescribe quinine with caution in patients at risk of QT prolongation, MHRA advises

New advice highlights that quinine can have effects...

Warfarin interaction warning for miconazole oral gel

Warfarin interaction warning for miconazole oral gel

Miconazole oral gel should be prescribed with caution...

Stopping statins after stroke linked to higher risk of recurrent stroke

Stopping statins after stroke linked to higher risk of recurrent stroke

Patients who stop statin therapy 3 to 6 months after...

Anticoagulant linked to rare calciphylaxis risk

Anticoagulant linked to rare calciphylaxis risk

Calciphylaxis, a rare but serious condition causing...

Selexipag: new class of treatment for pulmonary artery hypertension reaches prescribers

Selexipag: new class of treatment for pulmonary artery hypertension reaches prescribers

Uptravi (selexipag), a prostacyclin receptor agonist...

NICE approval for new class of lipid-lowering drugs

NICE approval for new class of lipid-lowering drugs

NHS clinicians must now have the option to prescribe...

Update: GPs warned about error in cardiovascular risk calculator

Update: GPs warned about error in cardiovascular risk calculator

GPs have been advised not to use the QRISK2 cardiovascular...

'Innovative' heart failure treatment approved by NICE

'Innovative' heart failure treatment approved by NICE

A new type of drug to treat heart failure, which could...

Ticagrelor approved for long-term treatment following MI

Ticagrelor approved for long-term treatment following MI

The antiplatelet treatment Brilique (ticagrelor) can...

New once-daily fibrate/statin combination

New once-daily fibrate/statin combination

Prescribers now have the option to prescribe fenofibrate...

Ezetimibe licensed to reduce the risk of cardiovascular events

Ezetimibe licensed to reduce the risk of cardiovascular events

Ezetrol (ezetimibe) can now be prescribed to reduce...

Spironolactone hyperkalaemia warning over co-administration

Spironolactone hyperkalaemia warning over co-administration

Monitoring of blood electrolytes is essential when...

First reversal agent available for non-coumarin oral anticoagulant

First reversal agent available for non-coumarin oral anticoagulant

Idarucizumab (Praxbind) rapidly reverses the anticoagulant...

Entresto (sacubitril/valsartan): new heart failure combination tablet 'could replace ACE inhibitors as mainstay of treatment'

Entresto (sacubitril/valsartan): new heart failure combination tablet 'could replace ACE inhibitors as mainstay of treatment'

A combination of valsartan and the new drug sacubitril...

Nicorandil use restricted over ulceration risk

Nicorandil use restricted over ulceration risk

The anti-anginal nicorandil must only be used when...

New injectable antibody alirocumab enhances lipid-lowering effect of statins

New injectable antibody alirocumab enhances lipid-lowering effect of statins

Praluent (alirocumab) is the second lipid-lowering...

New lipid-lowering antibody evolocumab provides additional benefit to statins

New lipid-lowering antibody evolocumab provides additional benefit to statins

Evolocumab (Repatha) is the first in a new class of...

First approved treatment for severe orthostatic hypotension

First approved treatment for severe orthostatic hypotension

Midodrine (Bramox) provides prescribers with a licensed...

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more